Encompass Health Rehabilitation Institute of Libertyville Opens

A 60-bed inpatient rehabilitation hospital

Encompass Health (NYSE: EHC) announces the opening of Encompass Health Rehabilitation Institute of Libertyville, a 60-bed inpatient rehabilitation hospital located at 1201 American Way.

The hospital serves patients recovering from debilitating illnesses and injuries including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.

In addition to 24-hour nursing care, Encompass Health Rehabilitation Institute of Libertyville offers physical, occupational and speech therapies to restore functional ability and quality of life. Care is provided by highly specialized nurses, therapists and physicians. The hospital features all private patient rooms, a large therapy gym with advanced rehabilitation technologies and an activities of daily living suite, a therapy courtyard, a cafeteria and a dayroom.

“We are excited to open this new hospital in Libertyville to help restore function, strength, hope and confidence to individuals recovering from major illnesses and injuries with the ultimate goal of helping them return to the community at their highest levels of independence,” said Jennifer Weiss, CEO of Encompass Health Rehabilitation Institute of Libertyville. “This state-of-the-art hospital combined with our team of experts and advanced technologies will allow Northern Illinois residents to receive superior, specialized care close to home.”

Encompass Health Rehabilitation Institute of Libertyville is Encompass Health’s 147th inpatient rehabilitation hospital and its third inpatient rehabilitation hospital in Illinois, with another hospital expected to open in Illinois this year.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy